EP3665156A4
(en )
2021-04-28
Compounds, compositions and methods
EP3697376B8
(en )
2022-03-09
Composition
EP3607072A4
(en )
2021-01-06
Compositions and methods for treating phenylketonuria
AU2018242623B2
(en )
2024-05-02
Compounds and compositions for treating hematological disorders
EP3261644A4
(en )
2018-07-25
Compositions and methods for treating retinal degradation
EP3280262A4
(en )
2018-09-26
Synergistic benzoxaborole-containing anti-fungicidal composition
EP3609528A4
(en )
2020-12-23
Compositions for treating addiction
EP3584364A4
(en )
2020-01-15
Composition
EP3139949A4
(en )
2017-11-29
Methods and compositions for treating cystic fibrosis
EP3870210A4
(en )
2022-10-19
Compositions and methods for treating or preventing fibrosis
EP3256589A4
(en )
2018-10-31
Compositions and methods for controlling leptinotarsa
EP3226873A4
(en )
2018-08-08
Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same
EP3288636A4
(en )
2019-01-16
Compositions for the treatment of epistaxis
EP3801620A4
(en )
2022-04-20
Compositions and methods for treating pancreatitis
AU2018301500A1
(en )
2020-01-30
Methods and compositions for treating inflammation
EP3256124A4
(en )
2018-09-26
Cenicriviroc for the treatment of fibrosis
EP3755328A4
(en )
2021-11-10
Compositions and methods for treating pruritus
EP3694517A4
(en )
2021-07-14
Compositions and methods for treatment of fibrosis
PL3568203T3
(en )
2024-02-26
Compounds and compositions
EP3271320A4
(en )
2018-11-14
Compositions for the treatment of fibrosis and fibrosis-related conditions
EP3713578A4
(en )
2021-08-04
Compositions for preventing or treating lupus
EP3481199A4
(en )
2019-12-25
Compounds and compositions for biofilm prevention
EP3194446A4
(en )
2018-03-14
Compositions and methods for treating fibrosis
HK40098110A
(en )
2024-03-28
Compounds and compositions for treating fibrosis
HK40116800A
(en )
2025-05-02
Compositions and method for treating depression